Details for 2020900863
Up to date per 03.04.2026
Actions
Details for 2020900863
Granted/Registered
European Patent
26.10.2022 A
28.01.2026 B1
19.12.2019
US
201962950828 P
A61K 31/4985 20060101AFI20231124BHEP
Owner
Intra-Cellular Therapies, Inc.135 Route 202/206, Suite 6 Bedminster, NJ 07921US
Representative
No representatives present
Inventor
DAVIS, Robert E.c/o Intra-Cellular Therapies, Inc. 430 East 29th Street Suite 900 New York, New York 10016US
VANOVER, Kimberlyc/o Intra-Cellular Therapies, Inc. 430 East 29th Street Suite 900 New York, New York 10016US
Information about Fees